(Updated - August 28, 2026 7:30 AM EDT)

Argus analyst John Eade upgraded Moderna (NASDAQ: MRNA) from Hold to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE